Humana Inc: Form 10-Q for the period ended Sep 30, 2015
Filed with the SEC on Nov 6, 2015 and accepted by EDGAR at Nov 6, 2015, 09:11 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-07-01 to 2015-09-30 | $13.36bn | us-gaap:Revenues |
| Revenue | 9 months2015-01-01 to 2015-09-30 | $40.93bn | us-gaap:Revenues |
| Selling, general and administrative | 3 months2015-07-01 to 2015-09-30 | $1.69bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2015-01-01 to 2015-09-30 | $5.45bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2015-07-01 to 2015-09-30 | $695.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2015-01-01 to 2015-09-30 | $2.06bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2015-07-01 to 2015-09-30 | $47.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2015-01-01 to 2015-09-30 | $140.0m | us-gaap:InterestExpense |
| Income tax | 3 months2015-07-01 to 2015-09-30 | $334.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2015-01-01 to 2015-09-30 | $1.01bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2015-07-01 to 2015-09-30 | $314.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2015-01-01 to 2015-09-30 | $1.18bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2015-07-01 to 2015-09-30 | $2.09 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2015-01-01 to 2015-09-30 | $7.77 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2015-07-01 to 2015-09-30 | $2.11 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2015-01-01 to 2015-09-30 | $7.85 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2015-07-01 to 2015-09-30 | 150,466,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2015-01-01 to 2015-09-30 | 151,321,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2015-01-01 to 2015-09-30 | $531.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2015-01-01 to 2015-09-30 | $384.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2015-01-01 to 2015-09-30 | $129.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2015-01-01 to 2015-09-30 | $380.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2015-09-30 | $1.60bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-09-30 | $15.77bn | us-gaap:AssetsCurrent |
| Total assets | At period end2015-09-30 | $24.30bn | us-gaap:Assets |
| Current liabilities | At period end2015-09-30 | $7.74bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-09-30 | $13.94bn | us-gaap:Liabilities |
| Long-term debt | At period end2015-09-30 | $3.82bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2015-09-30 | $11.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2015-09-30 | $10.35bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2015-09-30 | 148,223,927 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000049071-15-000098. Last ingested by Listed: Nov 10, 2026, 02:47 ET. Listed shows no prices and gives no investment advice.